Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Kidney transplant patients often have skin issues, mainly infections.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

A man with severe hair loss regrew hair after hormone treatment.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

A genetic marker linked to a type of hair loss was found in most patients studied.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.